D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections
Abstract The excessive use of antifungal agents, compounded by the shortage of new drugs being introduced into the market, is causing the accumulation of multi-resistance phenotypes in many fungal strains. Consequently, new alternative molecules to conventional antifungal agents are urgently needed...
Saved in:
Main Authors: | Pauline Dartevelle, Claire Ehlinger, Abdurraouf Zaet, Christian Boehler, Morgane Rabineau, Benoit Westermann, Jean-Marc Strub, Sarah Cianferani, Youssef Haïkel, Marie-Hélène Metz-Boutigue, Céline Marban |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/6542be9b5ef34063b0fd3b1f1dd72f6f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Catestatin in innate immunity and Cateslytin-derived peptides against superbugs
by: Francesco Scavello, et al.
Published: (2021) -
Strongly Adhesive and Antimicrobial Peptide-Loaded, Alginate–Catechol-Based Gels for Application against Periimplantitis
by: Sébastien Baixe, et al.
Published: (2021) -
IN VITRO ANTIFUNGAL ACTIVITY OF POTASH ALUM AGAINST CANDIDA ALBICANS ON ACRYLIC RESIN
by: Muhammad Irshad, et al.
Published: (2020) -
Mechanisms of the antifungal action of marine metagenome-derived peptide, MMGP1, against Candida albicans.
by: Muthuirulan Pushpanathan, et al.
Published: (2013) -
Antifungal Effects and Potential Mechanisms of Benserazide Hydrochloride Alone and in Combination with Fluconazole Against Candida albicans
by: Chen X, et al.
Published: (2021)